Tag School of Medicine and Public Health
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer
A team of UW–Madison scientists have uncovered that bile acids produced by the liver to help digest food may affect our risk for developing colon cancer.
From stem cells to technology, the next Wisconsin RISE initiative focuses on improving health
The next focus area of the Wisconsin RISE Initiative, RISE-THRIVE, is set to harness and grow the university's reputation as a global powerhouse in interdisciplinary health research — translating both medical discoveries and innovative social science approaches into tangibly healthier lives for Wisconsinites and people and communities around the world.
A stealth fungus has decimated North American bats but scientists may be a step closer to treating white-nose syndrome
Scientists have discovered how an invasive fungus that colonizes the skin of hibernating bats gains entry and covertly hijacks cells, taking an important step toward treatment of white-nose syndrome.
Federal funds awarded for biohealth, with UW–Madison leading the way
The U.S. Economic Development Administration has announced $49 million in Phase 2 funding to the Wisconsin Biohealth Tech Hub, a groundbreaking initiative set to drive transformative medical innovation, workforce development and critical job growth across Wisconsin.
UW–Madison leading new research collaboration aimed at treating lung scarring diseases
An interdisciplinary group of researchers will will investigate the biological processes that promote lung scarring. With the aid of artificial intelligence and advanced 3D modeling, they will also develop and refine new imaging techniques and drug delivery systems that could aid in halting its progression.
Search begins for next dean of the School of Medicine and Public Health
A search committee has been appointed to help identify and select candidates to be the next dean of the University of Wisconsin School of Medicine and Public Health and vice chancellor for medical affairs.
Pancreatic cancer is difficult to treat. Nano-drugs hitching a ride on bacteria could help.
Mice treated with the therapeutic-laden bacteria experienced delayed tumor growth and significantly longer survival compared with mice that received other treatments.
Three honored for innovation, entrepreneurial excellence
Mark Bakken, James Dahlberg, and Dorri McWhorter received the 2024 Chancellor’s Entrepreneurial Achievement Awards. These entrepreneurs exemplify the Wisconsin Idea — UW–Madison’s longstanding commitment to benefiting the world beyond the boundaries of campus.
All creatures great and small: Sequencing the blue whale and Etruscan shrew genomes
Size doesn’t matter when it comes to genome sequencing in the animal kingdom, as a team of researchers at the Morgridge Institute for Research recently illustrated when assembling the sequences for two new reference genomes — one from the world’s largest mammal and one from one of the smallest.
Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.
Researchers have been trying to understand why and how certain lymphoma treatments often stop being effective. Lixin Rui and his team believe they've found the reason — and a potential alternative treatment.
Air sampling at schools accurately detects flu and COVID-19 virus levels
A new study from the Wisconsin School of Medicine and Public Health found that air samplers placed in school cafeterias provided an accurate read of flu and COVID-19 infections in a K-12 school district.
Golden to step down as dean of School of Medicine and Public Health
As one of the longest-serving medical school deans in North America, Golden has led extraordinary advancements in the educational, research and service missions of the school.
UW–Madison receives $150 million grant to to lead nationwide Alzheimer’s disease study
The five-year study will provide state-of-the-art imaging and blood-based biomarkers for researchers around the world to study and advance the field of Alzheimer’s and related dementias. The work is also designed to shed light on mixed dementia, where more than one neurological disease is contributing to dementia.
Mineral coatings could enable shelf-stable mRNA therapies
A protective mineral coating identified by University of Wisconsin–Madison biomedical engineering researchers could allow powerful messenger RNA therapeutics like COVID-19 vaccines to be stored at room temperature, making them more accessible to lower-resourced communities across the world.
Type 2 diabetes may contribute to racial disparities in colorectal cancer among Americans
The findings underscore the value of colonoscopies and other colorectal cancer screenings, especially for Black and lower-income Americans who on average suffer worse outcomes after a cancer diagnosis.
Mice eating less of specific amino acid — overrepresented in diet of obese people — live longer, healthier
A calorie may not be just a calorie according to new research from the University of Wisconsin School of Medicine and Public Health.
UW–Madison and GE HealthCare broaden shared commitment to health care innovation
The 10-year strategic collaboration builds on strong research foundations in medical imaging and expands the scope to advance the delivery of personalized and quality healthcare into 2030 and beyond.
Combining cell types may lead to improved cardiac cell therapy following heart attack
A new study from researchers at the University of Wisconsin–Madison and Academia Sinica of Taiwan points to an improved method for regenerating heart muscle following a heart attack.
Common chemotherapy drugs don’t work like doctors thought, with big implications for drug discovery
Findings reveal the likely reason why certain chemotherapies are effective for many patients. Importantly, they also help explain why attempts to find new chemo drugs based solely on stopping cellular division have been so disappointing.
Mixing donor and recipient immune systems creates tolerance of transplanted kidneys
Specialists at UW–Madison and Stanford University have developed the new approach to kidney transplantation that could one day help recipients tolerate a new organ without the need for anti-rejection medications.